Biophytis News

BPTSDelisted Stock  USD 7.03  0.00  0.00%   
Slightly above 56% of Biophytis' investor base is looking to short. The analysis of current outlook of investing in Biophytis suggests that many traders are alarmed regarding Biophytis' prospects. Biophytis' investing sentiment can be driven by a variety of factors including economic data, Biophytis' earnings reports, geopolitical events, and overall market trends.
  
over a year ago at news.google.com         
Biophytis has Requested a Pre-Submission Meeting with the EMA ... - GuruFocus.com
Google News at Macroaxis
over a year ago at news.google.com         
Biophytis has Requested a Pre-Submission Meeting with the EMA for the Marketing Authorisation of Sar...
Google News at Macroaxis
over a year ago at news.google.com         
Ur-Energy Releases 2023 Q1 Results - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Biophytis announces receipt of Nasdaq Notice - Yahoo Eurosport UK
Google News at Macroaxis
over a year ago at news.google.com         
Biophytis Price Target Decreased by 7.41 percent to 0.13 - Nasdaq
Google News at Macroaxis
over a year ago at accesswire.com         
Biophytis Regains Compliance with NASDAQ Minimum Bid Price Requirement
news
over a year ago at news.google.com         
Biophytis Announces 2022 Financial Results and 2023 Perspectives - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Biophytis Announces 2022 Financial Results and 2023 Perspectives - Yahoo Eurosport UK
Google News at Macroaxis
over a year ago at accesswire.com         
Biophytis The Combined General Meeting Will Be Held on Second Call on April 17, 2023
news
over a year ago at finance.yahoo.com         
Biophytis The Combined General Meeting Will Be Held on Second Call on April 17, 2023
Yahoo News
over a year ago at news.google.com         
Biophytis Biophytis Presented Sarconeos As A Possible Treatment Candidate for Long COVID After Hospi...
Google News at Macroaxis
over a year ago at news.google.com         
Biophytis announces ratio change under its American Depositary Receipt program - Marketscreener.com
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conferen...
Yahoo News
over a year ago at news.google.com         
Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conferen...
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Biophytis Announces the Signature of a Master Service Agreement With Intsel Chimos, a Pharmaceutical...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Biophytis that are available to investors today. That information is available publicly through Biophytis media outlets and privately through word of mouth or via Biophytis internal channels. However, regardless of the origin, that massive amount of Biophytis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biophytis news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biophytis relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biophytis' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biophytis alpha.

Biophytis Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Biophytis launches OBA phase 2 clinical study in obesity with BIO101
04/08/2024
2
Why Is Biophytis Stock Up 43 percent Today
04/09/2024
3
Biotech Catches Major Premarket Bid Following Financial Results - MSN
04/15/2024
4
Biophytis unveils design for obesity study - Marketscreener.com
05/14/2024
5
Biophytis Advances DMD Treatment with BIO101 Scale-Up - TipRanks.com - TipRanks
06/14/2024
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Biophytis Stock

If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities